Literature DB >> 19700394

Synovial immunopathological changes associated with successful abatacept therapy in a case of severe refractory psoriatic arthritis.

Juan D Cañete, Raquel Celis, Victoria Hernández, José Luis Pablos, Raimon Sanmartí.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19700394     DOI： 10.1136/ard.2009.113233

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

1.  Immunohistological analysis of synovium treated with abatacept in rheumatoid arthritis.

Authors:  Katsuaki Kanbe; Junji Chiba; Atsushi Nakamura
Journal:  Rheumatol Int       Date:  2012-01-03       Impact factor: 2.631

2.  Intimal lining layer macrophages but not synovial sublining macrophages display an IL-10 polarized-like phenotype in chronic synovitis.

Authors:  Carmen A Ambarus; Troy Noordenbos; Maria J H de Hair; Paul P Tak; Dominique L P Baeten
Journal:  Arthritis Res Ther       Date:  2012-04-11       Impact factor: 5.156

3.  Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study.

Authors:  Fernando Kemta Lekpa; Cécile Poulain; Daniel Wendling; Martin Soubrier; Michel De Bandt; Jean Marie Berthelot; Philippe Gaudin; Eric Toussirot; Philippe Goupille; Thao Pham; Jérémie Sellam; Rémy Bruckert; Muriel Paul; Valérie Farrenq; Pascal Claudepierre
Journal:  Arthritis Res Ther       Date:  2012-03-09       Impact factor: 5.156

Review 4.  Synovitis in psoriatic arthritis: immunohistochemistry, comparisons with rheumatoid arthritis, and effects of therapy.

Authors:  Arno W R van Kuijk; Paul P Tak
Journal:  Curr Rheumatol Rep       Date:  2011-08       Impact factor: 4.592

5.  Synovial tissue response to treatment in psoriatic arthritis.

Authors:  Veronica Codullo; Iain B McInnes
Journal:  Open Rheumatol J       Date:  2011-12-30

6.  Macrophages in synovial inflammation.

Authors:  Aisling Kennedy; Ursula Fearon; Douglas J Veale; Catherine Godson
Journal:  Front Immunol       Date:  2011-10-10       Impact factor: 7.561

7.  Abatacept in psoriatic arthritis: Case report and short review.

Authors:  Francesco Ursini; Saverio Naty; Emilio Russo; Rosa Daniela Grembiale
Journal:  J Pharmacol Pharmacother       Date:  2013-12

8.  Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis.

Authors:  Agnes Szentpetery; Eric Heffernan; Martina Gogarty; Lisa Mellerick; Janet McCormack; Muhammad Haroon; Musaab Elmamoun; Phil Gallagher; Genevieve Kelly; Aurelie Fabre; Brian Kirby; Oliver FitzGerald
Journal:  Arthritis Res Ther       Date:  2017-07-05       Impact factor: 5.156

9.  CTLA4-Ig treatment induces M1-M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients.

Authors:  Maurizio Cutolo; Stefano Soldano; Emanuele Gotelli; Paola Montagna; Rosanna Campitiello; Sabrina Paolino; Carmen Pizzorni; Alberto Sulli; Vanessa Smith; Samuele Tardito
Journal:  Arthritis Res Ther       Date:  2021-12-24       Impact factor: 5.156
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.